|
Originally published In Press as doi:10.1074/jbc.M212814200 on July 10, 2003
J. Biol. Chem., Vol. 278, Issue 38, 36603-36610, September 19, 2003
hMusTRD1 1 Represses MEF2 Activation of the Troponin I Slow Enhancer*
Patsie Polly ,
Leila M. Haddadi,
Laura L. Issa ,
Nanthakumar Subramaniam,
Stephen J. Palmer,
Enoch S. E. Tay and
Edna C. Hardeman ¶
From the
Muscle Development Unit, Children's Medical Research Institute, Wentworthville, New South Wales 2145, Australia
The novel transcription factor hMusTRD1 1 (human muscle TFII-I repeat domain-containing protein 1 1; previously named MusTRD1; O'Mahoney, J. V., Guven, K. L., Lin, J., Joya, J. E., Robinson, C. S., Wade, R. P., and Hardeman, E. C. (1998) Mol. Cell. Biol. 18, 66416652) was identified in a yeast one-hybrid screen as a protein that binds within an upstream enhancer-containing region of the skeletal muscle-specific gene, TNNI1 (human troponin I slow; hTnIslow). It has been proposed that hMusTRD1 1 may play an important role in fiber-specific muscle gene expression by virtue of its ability to bind to an Inr-like element (nucleotides 977 to 960) within the hTnIslow upstream enhancer-containing region that is necessary for slow fiber-specific expression. In this study we demonstrate that both MEF2C, a known regulator of slow fiber-specific genes, and hMusTRD1 1 regulate hTnIslow through the Inr-like element. Co-transfection assays in C2C12 cells and Cos-7 cells demonstrate that hMusTRD1 1 represses hTnIslow transcription and prevents MEF2C-mediated activation of hTnIslow transcription. Gel shift analysis shows that hMusTRD1 1 can abrogate MEF2C binding to its cognate site in the hTnIslow enhancer. Glutathione S-transferase pull-down assays demonstrate that hMusTRD1 1 can interact with both MEF2C and the nuclear receptor co-repressor. The data support the role of hMusTRD1 1 as a repressor of slow fiber-specific transcription through mechanisms involving direct interactions with MEF2C and the nuclear receptor co-repressor.
Received for publication, December 17, 2002
, and in revised form, June 13, 2003.
* This work was supported by an National Health and Medical Research Council grant (to E. C. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Recipient of a Howard Florey Centenary fellowship from the National Health and Medical Research Council of Australia.
Present address: Victor Chang Cardiac Research Institute, Darlinghurst, NSW 2010, Australia.
¶ To whom correspondence should be addressed: Muscle Development Unit, Children's Medical Research Inst., Locked Bag 23, Wentworthville, NSW 2145, Australia. E-mail: ehardeman{at}cmri.usyd.edu.au.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
N.-O. Chimge, A. V. Makeyev, F. H. Ruddle, and D. Bayarsaihan
Identification of the TFII-I family target genes in the vertebrate genome
PNAS,
July 1, 2008;
105(26):
9006 - 9010.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Zhao, L. A. Schriefer, and G. D. Stormo
Identification of muscle-specific regulatory modules in Caenorhabditis elegans
Genome Res.,
March 1, 2007;
17(3):
348 - 357.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Vullhorst and A. Buonanno
Multiple GTF2I-like Repeats of General Transcription Factor 3 Exhibit DNA Binding Properties: EVIDENCE FOR A COMMON ORIGIN AS A SEQUENCE-SPECIFIC DNA INTERACTION MODULE
J. Biol. Chem.,
September 9, 2005;
280(36):
31722 - 31731.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. A. Jackson, H. E. Taylor, D. Sharma, S. Desiderio, and S. K. Danoff
Vascular Endothelial Growth Factor Receptor-2: COUNTER-REGULATION BY THE TRANSCRIPTION FACTORS, TFII-I AND TFII-IRD1
J. Biol. Chem.,
August 19, 2005;
280(33):
29856 - 29863.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Ku, S. Y. Sokol, J. Wu, M. I. Tussie-Luna, A. L. Roy, and A. Hata
Positive and Negative Regulation of the Transforming Growth Factor {beta}/Activin Target Gene goosecoid by the TFII-I Family of Transcription Factors
Mol. Cell. Biol.,
August 15, 2005;
25(16):
7144 - 7157.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. W. Baker, K. K. K. Tanaka, N. Klitgord, and R. M. Cripps
Adult Myogenesis in Drosophila melanogaster Can Proceed Independently of Myocyte Enhancer Factor-2
Genetics,
August 1, 2005;
170(4):
1747 - 1759.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Youn, Y. Koo, I. Ji, and T. H. Ji
An Upstream Initiator-Like Element Suppresses Transcription of the Rat Luteinizing Hormone Receptor Gene
Mol. Endocrinol.,
May 1, 2005;
19(5):
1318 - 1328.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. V. Makeyev, L. Erdenechimeg, O. Mungunsukh, J. J. Roth, B. Enkhmandakh, F. H. Ruddle, and D. Bayarsaihan
GTF2IRD2 is located in the Williams-Beuren syndrome critical region 7q11.23 and encodes a protein with two TFII-I-like helix-loop-helix repeats
PNAS,
July 27, 2004;
101(30):
11052 - 11057.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Tantin, M. I. Tussie-Luna, A. L. Roy, and P. A. Sharp
Regulation of Immunoglobulin Promoter Activity by TFII-I Class Transcription Factors
J. Biol. Chem.,
February 13, 2004;
279(7):
5460 - 5469.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|